Info & imagens

ESTIMATING RECURRENCES PREVENTED AND COSTS AVOIDED WITH ATEZOLIZUMAB IN EARLY NON-SMALL CELL LUNG CANCER UNDER THE BRAZILIAN SUPPLEMENTARY HEALTH SYSTEM PERSPECTIVE

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Authors

Salvalaggio, Paolo

About the Journal

Journal: Brazilian Journal of Oncology

DOI: 10.1055/s-00059887

e-issn: 2526-8732

Publisher: Thieme Revinter Publicações Ltda.

Publisher address: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Conference

XXIII Congresso Brasileiro de Oncologia Clínica

Local: Windsor Convention & Expo Center

Data: November 3, 2022